|
TSFM expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.413880E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.841530E-02 |
| Normal-vs-Stage2 |
4.904400E-01 |
| Normal-vs-Stage3 |
6.576200E-01 |
| Normal-vs-Stage4 |
4.656000E-01 |
| Stage1-vs-Stage2 |
8.626200E-01 |
| Stage1-vs-Stage3 |
3.494000E-01 |
| Stage1-vs-Stage4 |
9.943000E-01 |
| Stage2-vs-Stage3 |
6.880000E-01 |
| Stage2-vs-Stage4 |
9.150800E-01 |
| Stage3-vs-Stage4 |
6.057800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.819500E-02 |
| Normal-vs-AfricanAmerican |
8.152700E-04 |
| Normal-vs-Asian |
6.301000E-01 |
| Caucasian-vs-AfricanAmerican |
5.915800E-03 |
| Caucasian-vs-Asian |
3.982000E-01 |
| AfricanAmerican-vs-Asian |
1.282790E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.382200E-03 |
| Normal-vs-Female |
2.488600E-01 |
| Male-vs-Female |
2.436400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.878200E-01 |
| Normal-vs-Extreme_Weight |
1.265160E-01 |
| Normal-vs-Obese |
1.535830E-01 |
| Normal-vs-Extreme_Obese |
4.763200E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.230400E-01 |
| Normal_Weight-vs-Obese |
8.169600E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.482800E-01 |
| Extreme_Weight-vs-Obese |
9.796800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.002400E-01 |
| Obese-vs-Extreme_Obese |
8.135000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.829600E-02 |
| Normal-vs-Age(41-60Yrs) |
5.396300E-02 |
| Normal-vs-Age(61-80Yrs) |
5.088300E-02 |
| Normal-vs-Age(81-100Yrs) |
6.787000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.417000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.387400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.280800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.627600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.607000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.794400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.378150E-04 |
| Normal-VS-Type2 PRCC |
8.574400E-01 |
| Normal-VS-KIRP CIMP |
8.909800E-01 |
| Normal-VS-Unclassified PRCC |
3.325600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
4.403000E-04 |
| Type1 PRCC-VS-KIRP CIMP |
2.308400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.368570E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.352200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.038000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
6.799000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.038600E-01 |
| Normal-vs-N1 |
3.811200E-01 |
| Normal-vs-N2 |
7.386000E-01 |
| N0-vs-N1 |
9.815600E-01 |
| N0-vs-N2 |
4.818200E-01 |
| N1-vs-N2 |
4.469600E-01 |
|
|
